PEAK6 Group’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-36,000
Closed -$976K 5548
2015
Q4
$976K Sell
36,000
-5,000
-12% -$129K 0.01% 1940
2015
Q3
$897K Sell
41,000
-5,800
-12% -$148K ﹤0.01% 2297
2015
Q2
$1.33M Sell
46,800
-4,300
-8% -$125K 0.01% 1818
2015
Q1
$1.4M Buy
+51,100
New +$1.41M 0.01% 1559
2014
Q4
Sell
-8,000
Closed -$241K 5584
2014
Q3
$241K Buy
+8,000
New +$248K ﹤0.01% 3144
2013
Q4
Sell
-10,400
Closed -$202K 5860
2013
Q3
$202K Buy
+10,400
New +$419K ﹤0.01% 3683

Other funds holding MR

PEAK6 Group's MR Position: Q1 2016 in Review

PEAK6 Group sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 213,149 shares — an estimated $5.78M sold.

PEAK6 Group first reported a position in MR in Q4 2013 and held it in 4 quarters. The position peaked at $5.78M in Q4 2015. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

  • PEAK6 Group reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
  • PEAK6 Group sold 213,149 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $5.78M.
  • PEAK6 Group first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q4 2013 and held it in 4 quarters.
  • PEAK6 Group's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $5.78M in Q4 2015.
  • 2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on PEAK6 Group's 13F filing for Q1 2016, filed 13 May 2016.